TWI840716B - Electrochemical pump and its drug-delivery device - Google Patents
Electrochemical pump and its drug-delivery device Download PDFInfo
- Publication number
- TWI840716B TWI840716B TW110140846A TW110140846A TWI840716B TW I840716 B TWI840716 B TW I840716B TW 110140846 A TW110140846 A TW 110140846A TW 110140846 A TW110140846 A TW 110140846A TW I840716 B TWI840716 B TW I840716B
- Authority
- TW
- Taiwan
- Prior art keywords
- electrochemical pump
- container
- opening
- contacts
- electrolyte
- Prior art date
Links
- 238000012377 drug delivery Methods 0.000 title claims abstract description 20
- 239000003792 electrolyte Substances 0.000 claims abstract description 38
- 239000004020 conductor Substances 0.000 claims abstract description 15
- 239000003814 drug Substances 0.000 claims abstract description 14
- 229940079593 drug Drugs 0.000 claims abstract description 14
- 239000000758 substrate Substances 0.000 claims abstract description 11
- 125000006850 spacer group Chemical group 0.000 claims abstract description 9
- 239000000463 material Substances 0.000 claims description 24
- 229920000954 Polyglycolide Polymers 0.000 claims description 9
- 239000004633 polyglycolic acid Substances 0.000 claims description 9
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 8
- 229920001971 elastomer Polymers 0.000 claims description 7
- 239000004626 polylactic acid Substances 0.000 claims description 7
- 239000005060 rubber Substances 0.000 claims description 7
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 6
- 229920001610 polycaprolactone Polymers 0.000 claims description 6
- 239000004632 polycaprolactone Substances 0.000 claims description 6
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 6
- 239000012528 membrane Substances 0.000 claims description 5
- 229920002125 Sokalan® Polymers 0.000 claims description 4
- 229920000747 poly(lactic acid) Polymers 0.000 claims description 3
- 239000004584 polyacrylic acid Substances 0.000 claims description 3
- 229920005594 polymer fiber Polymers 0.000 claims description 3
- 239000008151 electrolyte solution Substances 0.000 abstract description 3
- 239000007789 gas Substances 0.000 description 10
- -1 polypropylene Polymers 0.000 description 9
- 238000002347 injection Methods 0.000 description 8
- 239000007924 injection Substances 0.000 description 8
- 238000000034 method Methods 0.000 description 7
- 229920002725 thermoplastic elastomer Polymers 0.000 description 6
- 238000003487 electrochemical reaction Methods 0.000 description 4
- 229920006132 styrene block copolymer Polymers 0.000 description 4
- 238000005192 partition Methods 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 229920000089 Cyclic olefin copolymer Polymers 0.000 description 2
- 229920001609 Poly(3,4-ethylenedioxythiophene) Polymers 0.000 description 2
- 229920001665 Poly-4-vinylphenol Polymers 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000000708 deep reactive-ion etching Methods 0.000 description 2
- 230000005684 electric field Effects 0.000 description 2
- 239000003822 epoxy resin Substances 0.000 description 2
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 2
- 238000001020 plasma etching Methods 0.000 description 2
- 238000009832 plasma treatment Methods 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 229920001197 polyacetylene Polymers 0.000 description 2
- 229920000767 polyaniline Polymers 0.000 description 2
- 229920000647 polyepoxide Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 239000004926 polymethyl methacrylate Substances 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 229920000128 polypyrrole Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 229920000123 polythiophene Polymers 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 229940126585 therapeutic drug Drugs 0.000 description 2
- 238000003466 welding Methods 0.000 description 2
- LLLVZDVNHNWSDS-UHFFFAOYSA-N 4-methylidene-3,5-dioxabicyclo[5.2.2]undeca-1(9),7,10-triene-2,6-dione Chemical compound C1(C2=CC=C(C(=O)OC(=C)O1)C=C2)=O LLLVZDVNHNWSDS-UHFFFAOYSA-N 0.000 description 1
- 239000004925 Acrylic resin Substances 0.000 description 1
- 229920000178 Acrylic resin Polymers 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 244000043261 Hevea brasiliensis Species 0.000 description 1
- 229920000557 Nafion® Polymers 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 238000003486 chemical etching Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229920001940 conductive polymer Polymers 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000000609 electron-beam lithography Methods 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000005350 fused silica glass Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000009616 inductively coupled plasma Methods 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229920003052 natural elastomer Polymers 0.000 description 1
- 229920001194 natural rubber Polymers 0.000 description 1
- 150000002926 oxygen Chemical class 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000012536 packaging technology Methods 0.000 description 1
- 238000000206 photolithography Methods 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000323 polyazulene Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920002098 polyfluorene Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920000417 polynaphthalene Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- BFKJFAAPBSQJPD-UHFFFAOYSA-N tetrafluoroethene Chemical group FC(F)=C(F)F BFKJFAAPBSQJPD-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Abstract
Description
本揭露係關於一種電化學幫浦及其藥劑遞送裝置,用於自動遞送藥劑。The present disclosure relates to an electrochemical pump and a drug delivery device thereof, which are used for automatically delivering drugs.
近來於製藥業,電化學式幫浦用於遞送治療藥劑之技術被認為是可進一步研發改良之領域。但傳統上治療藥劑之遞送所使用之電化學幫浦的設計存在缺陷仍待改善。例如,使用微電極結構之電化學幫浦其電解液的高阻抗與低局部電場,造成之高功率損耗;以及,較低之電極表面固態自由能,以上兩者均造成的幫浦整體系統之高功率能耗之問題。Recently, in the pharmaceutical industry, the use of electrochemical pumps for the delivery of therapeutic drugs has been considered an area that can be further developed and improved. However, the design of electrochemical pumps used for the delivery of therapeutic drugs has defects that need to be improved. For example, the high impedance and low local electric field of the electrolyte in electrochemical pumps using microelectrode structures cause high power loss; and the lower solid free energy of the electrode surface, both of which cause high power consumption of the overall pump system.
另,傳統電化學幫浦之電極與接觸板通常位於基板同一側,導致控制電路板與電極之連接結構材料在電化學反應時不可避免地遭到電化學電解液腐蝕之問題,嚴重影響整體電化學幫浦系統之運作與能耗表現。In addition, the electrodes and contact plates of traditional electrochemical pumps are usually located on the same side of the substrate, which causes the connection structure materials between the control circuit board and the electrode to be inevitably corroded by the electrochemical electrolyte during the electrochemical reaction, seriously affecting the operation and energy consumption performance of the entire electrochemical pump system.
電化學式藥劑遞送醫療裝置的作動機制主要是藉由產生氣體之壓力來做為驅動之動力來源,例如:利用藥劑輸送裝置之內部與裝置周圍環境之間的壓力差,進而輸出藥劑。但,精準控制裝置內產生之壓力幅度需要先進的裝置結(機)構設計與電控裝置設計,以上結構與電控系統的錯誤設計可能導致難以精確控制氣體的產生量達到精準控制少量藥劑與穩定藥物輸送速度之目的。The actuation mechanism of electrochemical drug delivery medical devices mainly uses the pressure of generated gas as the driving power source, for example: using the pressure difference between the inside of the drug delivery device and the surrounding environment of the device to deliver the drug. However, accurate control of the pressure amplitude generated in the device requires advanced device structure (mechanical) design and electronic control device design. The incorrect design of the above structure and electronic control system may make it difficult to accurately control the amount of gas generated to achieve the purpose of accurately controlling a small amount of drugs and stabilizing the drug delivery speed.
另,當需要藥劑遞送裝置輸出超高速流速來驅動高黏稠度藥劑時,該電化學裝置之動力輸出需要相應調高,使其具備輸出超大驅動力之能力,因此,電路板與電源也必須具備輸出超高輸出能量之能力。對於接觸板至電極間之同側結構設計來說,接觸板到電極中間之導線部(Lead)大幅度增加整體之電阻阻抗,進而嚴重影響能量由電源傳遞至電極間之能量損耗,因而大幅降低整體電化學幫浦系統之壓力動力輸出性能。In addition, when the drug delivery device is required to output an ultra-high flow rate to drive high-viscosity drugs, the power output of the electrochemical device needs to be increased accordingly so that it has the ability to output ultra-large driving force. Therefore, the circuit board and power supply must also have the ability to output ultra-high output energy. For the same-side structural design between the contact plate and the electrode, the lead part (Lead) between the contact plate and the electrode greatly increases the overall resistance impedance, which seriously affects the energy loss from the power supply to the electrodes, thereby greatly reducing the pressure power output performance of the overall electrochemical pump system.
此外,當需要以皮下注射或肌肉注射遞送大體積(如數毫升)高濃稠度之藥劑時,為了避免注射速度過快造成病人疼痛的問題,因此需時採取較溫和的注射速度與稍久之注射時間,若採用人力來手動注射遞送,不僅耗費人力,且亦難以精準控制藥劑遞送之速率來避免上述之疼痛問題。目前市面上自動遞送的裝置,多採用機械力(如彈簧)或以微型馬達來做為驅動動力之來源,但由於彈簧或微型馬達所引起的不穩定驅動力,可能會在注射過程中引起意想不到的疼痛,難以同時達到快速且穩定的遞送速度。In addition, when a large volume (such as several milliliters) of high-concentration drugs need to be delivered by subcutaneous or intramuscular injection, in order to avoid the problem of pain caused by too fast injection speed, a gentler injection speed and a slightly longer injection time are required. If manual injection delivery is used, it will not only consume manpower, but also be difficult to accurately control the drug delivery rate to avoid the above-mentioned pain problem. Currently, the automatic delivery devices on the market mostly use mechanical force (such as springs) or micro motors as the source of driving power, but the unstable driving force caused by springs or micro motors may cause unexpected pain during the injection process, and it is difficult to achieve a fast and stable delivery speed at the same time.
因此,本領域亟需改良並解決上述問題,開發一種不會因為電極與導線板位於同側造成腐蝕的電化學幫浦結構,同時降低阻抗增加大能量傳輸之效率、增加能量傳輸的控制精準度來減少疼痛,並兼具小體積的致動供藥裝置或方法。Therefore, there is an urgent need to improve and solve the above problems in this field, and to develop an electrochemical pump structure that will not cause corrosion due to the electrodes and the conductor plate being located on the same side, while reducing impedance to increase the efficiency of large energy transmission, increasing the control accuracy of energy transmission to reduce pain, and having a small-sized actuation drug delivery device or method.
為達成發明之目的,本揭露係提供一種用於藥劑遞送的電化學幫浦及其藥劑遞送裝置。其中,該電化學幫浦包括:一基板,具有一第一表面、一第二表面以及複數個通孔,其中該第二表面上具有複數個接點,該通孔中具有導電材料並電性連接該複數個接點;複數個電極,設置於該第一表面上,並藉由該複數個通孔中之導電材料與第二表面上的複數個接點電性連接;一電子裝置,設置於該第二表面上,並電性連接於該第二表面上之該些接點;以及一容置電解液之空間,其中具有電解液,且鄰接該第一表面,使該複數個電極與該電解液接觸。To achieve the purpose of the invention, the present disclosure provides an electrochemical pump for drug delivery and a drug delivery device thereof. The electrochemical pump includes: a substrate having a first surface, a second surface, and a plurality of through holes, wherein the second surface has a plurality of contacts, the through holes have conductive materials and are electrically connected to the plurality of contacts; a plurality of electrodes are disposed on the first surface and are electrically connected to the plurality of contacts on the second surface through the conductive materials in the plurality of through holes; an electronic device is disposed on the second surface and is electrically connected to the contacts on the second surface; and a space for containing electrolyte, wherein the electrolyte is contained and adjacent to the first surface, so that the plurality of electrodes are in contact with the electrolyte.
於一實施例,該些電極至少包括一陽極及一陰極。其中該些電極另包括一參考電極。其中該些電極另包括一冗餘電極。In one embodiment, the electrodes at least include an anode and a cathode, wherein the electrodes further include a reference electrode, and wherein the electrodes further include a redundant electrode.
於一實施例,其中該些電極其中任一係透過複數個通孔電性連接複數個接點。In one embodiment, any one of the electrodes is electrically connected to a plurality of contacts through a plurality of through holes.
於一實施例,該第一表面塗佈一親水層。In one embodiment, the first surface is coated with a hydrophilic layer.
於一實施例,該容置電解液之空間係由第一表面附加一超吸收材料所構成。In one embodiment, the space for accommodating the electrolyte is formed by attaching a superabsorbent material to the first surface.
於一實施例,其中該超吸收材料為一海棉。In one embodiment, the superabsorbent material is a sponge.
於一實施例,其中該超吸收材料為選自由下列組成之群的材料製成:聚乙烯醇(PVA)、聚環氧乙烷(PEO)、聚丙烯酸、聚乳酸(PLA)、聚乙醇酸(PGA)、PLA / PGA共聚物、聚己內酯(PCL) ,以及由前述材料所製造之高分子纖維製品。In one embodiment, the superabsorbent material is made of a material selected from the group consisting of: polyvinyl alcohol (PVA), polyethylene oxide (PEO), polyacrylic acid, polylactic acid (PLA), polyglycolic acid (PGA), PLA/PGA copolymer, polycaprolactone (PCL), and polymer fiber products made from the aforementioned materials.
於一實施例,該容置電解液之空間係由第一表面附加一透氣膜所構成,其中該容置電解液之空間以該透氣膜密封。In one embodiment, the space for containing electrolyte is formed by attaching a breathable membrane to the first surface, wherein the space for containing electrolyte is sealed by the breathable membrane.
於一實施例,該電子裝置包括:一電路板;一輸入端口;和一輸出端口。In one embodiment, the electronic device includes: a circuit board; an input port; and an output port.
於一實施例,該輸出端口係將該電路板電性連接至該電化學幫浦基板,該輸入端口一端電性連接至該電路板,另一端為電源之輸入口。In one embodiment, the output port electrically connects the circuit board to the electrochemical pump substrate, and one end of the input port is electrically connected to the circuit board, and the other end is an input port for power.
於一實施例,該電子裝置更包含一驅動電路構件。In one embodiment, the electronic device further includes a driving circuit component.
於一實施例,該電子裝置包括一電源。In one embodiment, the electronic device includes a power source.
於一實施例,該輸出端口係將該電路板電性連接至該些接點,該電源係經由該輸入端口電性連接至該電路板,以及該驅動電路構件係電性連接至該電路板並另一方面電性連接至該電源。In one embodiment, the output port electrically connects the circuit board to the contacts, the power source is electrically connected to the circuit board via the input port, and the drive circuit component is electrically connected to the circuit board and on the other hand electrically connected to the power source.
於一實施例,該電子裝置為可拆卸式。In one embodiment, the electronic device is detachable.
另一方面,本揭露提供一種藥劑遞送裝置,包括:一容器,容置一藥劑,具有彼此相對的一第一開口和一第二開口,其中該第一開口為該藥劑之輸出口;一間隔件,設置於該容器內界於兩開口間,可沿該容器壁自由滑動;以及該電化學幫浦,置於該第二開口,使該電化學幫浦與該容器緊密結合密封該第二開口。On the other hand, the present disclosure provides a drug delivery device, comprising: a container for accommodating a drug, having a first opening and a second opening opposite to each other, wherein the first opening is an outlet for the drug; a spacer disposed inside the container between the two openings and capable of sliding freely along the container wall; and an electrochemical pump disposed at the second opening, so that the electrochemical pump is tightly combined with the container to seal the second opening.
於一實施例,該容器為一注射筒,可進一步包含一注射針頭,設置於該第一開口。In one embodiment, the container is a syringe, which may further include an injection needle disposed at the first opening.
於一實施例,該容器為透明或半透明。In one embodiment, the container is transparent or translucent.
於一實施例,該容器為剛性或具有可撓性。In one embodiment, the container is rigid or flexible.
於一實施例,該間隔件係以一橡膠塞所構成。In one embodiment, the spacer is formed by a rubber plug.
本發明說明書及申請專利範圍中所述之所有技術性及科學用語,除非另有所定義,皆為本發明所屬技術領域具有通常知識者可知曉之定義。其中單數用語「一」、「一個」、「該」、或其近似用語,除非另有說明,皆可指涉多於一個對象。本說明書使用之「或」、「以及」、「和」,除非另有說明,皆指涉「或/和」。此外,用語「包含」、「包括」皆非有所限制之開放式連接詞。前述定義僅說明用語定義之指涉而不應解釋為對發明標的之限制。除非另有說明,本發明所用之材料皆為市售易於取得。All technical and scientific terms described in this specification and the scope of patent application, unless otherwise defined, are definitions that can be known to those with ordinary knowledge in the technical field to which the present invention belongs. The singular terms "one", "an", "the", or similar terms, unless otherwise specified, can refer to more than one object. "Or", "and", "and" used in this specification, unless otherwise specified, all refer to "or/and". In addition, the terms "include" and "include" are open conjunctions without restrictions. The above definitions only illustrate the references of the term definitions and should not be interpreted as limitations on the subject matter of the invention. Unless otherwise specified, the materials used in the present invention are all commercially available and easily available.
本說明書和請求項所提及的序數,例如「第一」、「第二」等,僅用於說明所揭露之元件,而非指稱或表示元件之間具有任何執行次序,亦非指稱或表示於一元件和另一元件之間的次序、或製程之步驟次序。該些序數僅用於使具有某命名的一元件得以和另一具有相同命名的元件能清楚區分。The ordinal numbers mentioned in the specification and claims, such as "first", "second", etc., are only used to describe the disclosed elements, and do not refer to or indicate any execution order between the elements, nor do they refer to or indicate the order between one element and another element, or the order of steps in a process. These ordinal numbers are only used to make a component with a certain name clearly distinguishable from another component with the same name.
另,本說明書用語「上」、「之上」、「上方」、或相似用語指涉一元件與另一元件(例如基板)直接接觸,但亦指涉一元件與另一元件(例如基板)不直接接觸。In addition, the terms “on”, “above”, “above”, or similar terms used in this specification refer to a component being in direct contact with another component (such as a substrate), but also refer to a component being in non-direct contact with another component (such as a substrate).
實施例Embodiment
如圖1所示,本揭露係提供一種電化學幫浦10,該電化學幫浦10包括:一基板101;一容置電解液之空間102;複數個電極103;以及一電子裝置104。As shown in FIG. 1 , the present disclosure provides an electrochemical pump 10 , which includes: a substrate 101 ; a space 102 for containing an electrolyte; a plurality of electrodes 103 ; and an electronic device 104 .
該基板101具有一第一表面1011、一第二表面1012、複數個通孔1013、複數個導電材料1014及複數個接點1015。該些接點1015係設置於該些通孔1013位於該第二表面1012之一側,且該些通孔1013內具有導電材料1014,因此可使該第一表面1011上之元件和該第二表面1012上之元件得以電性連接。該容置電解液之空間102設置於該第一表面1011之上,其中具有電解液1021。該些電極103設置於該第一表面1011,其與該電解液1021直接接觸,並與該通孔1013內之導電材料1014電性連接。該電子裝置104設置於該第二表面1012之上,並且與該些接點1015電性連接。The substrate 101 has a first surface 1011, a second surface 1012, a plurality of through holes 1013, a plurality of conductive materials 1014 and a plurality of contacts 1015. The contacts 1015 are arranged on one side of the through holes 1013 located on the second surface 1012, and the conductive materials 1014 are arranged in the through holes 1013, so that the components on the first surface 1011 and the components on the second surface 1012 can be electrically connected. The space 102 for accommodating electrolyte is arranged on the first surface 1011, and contains electrolyte 1021. The electrodes 103 are arranged on the first surface 1011, and are in direct contact with the electrolyte 1021, and are electrically connected to the conductive material 1014 in the through holes 1013. The electronic device 104 is disposed on the second surface 1012 and is electrically connected to the contacts 1015 .
於本揭露,可藉由於通孔1013內填充導電材料、塗佈導電材料層於通孔壁,或置入導線等方式使通孔1013兩側得以電性連結,然其技術手段應不限於此。於本揭露,該些通孔1013與其中的導電材料1014可以透過使用在互補式金屬氧化物半導體(CMOS)製程與積體電路(IC)封裝技術中廣泛使用的饋通(feedthrough)技術完成,藉此達成「濕」結構 (即第一表面上之各種結構,該結構與電解液直接接觸) 與「乾」結構 (即第二表面上與該面接觸之各種結構,如電子裝置) 的完全分隔,避免電解液與電子裝置之直接接觸,以強化該整體裝置的可靠性。In the present disclosure, the two sides of the through hole 1013 can be electrically connected by filling the through hole 1013 with a conductive material, coating the through hole wall with a conductive material layer, or inserting a wire, but the technical means should not be limited to this. In the present disclosure, the through holes 1013 and the conductive material 1014 therein can be completed by using the feedthrough technology widely used in the complementary metal oxide semiconductor (CMOS) process and integrated circuit (IC) packaging technology, thereby achieving a complete separation of the "wet" structure (i.e., various structures on the first surface, which are in direct contact with the electrolyte) and the "dry" structure (i.e., various structures on the second surface that are in direct contact with the surface, such as electronic devices), avoiding direct contact between the electrolyte and the electronic device, so as to enhance the reliability of the overall device.
於一具體實施例,該些接點1015為複數個接觸墊(contact pad)。In one embodiment, the contacts 1015 are a plurality of contact pads.
於本揭露,該容置電解液之空間102為第一表面附加一超吸收材料(superabsorbent material)所構成,或第一表面附加一透氣膜所構成。於一具體實施例,該容置電解液之空間102為一塗佈於第一表面1011上之超吸收材料,將電解液1021製成凝膠狀,以保持該些電極103與該電解液1021接觸,且使該些電解液不致洩漏,並允許產生之氣體離開該容置電解液之空間102;該電解液1021為經電極可產生氣體之溶液,例如水或電解質溶液,但不應受限於此。In the present disclosure, the electrolyte space 102 is formed by attaching a superabsorbent material to the first surface, or attaching a breathable film to the first surface. In a specific embodiment, the electrolyte space 102 is a superabsorbent material coated on the first surface 1011, and the electrolyte 1021 is made into a gel state to keep the electrodes 103 in contact with the electrolyte 1021, and to prevent the electrolyte from leaking, and to allow the generated gas to leave the electrolyte space 102; the electrolyte 1021 is a solution that can generate gas through the electrode, such as water or an electrolyte solution, but should not be limited thereto.
於一較佳實施例,該超吸收材料為一海棉。在另一具體實施例中,該超吸收材料係被附加至該些電極103表面,該超吸收材料為選自由下列組成之群的材料製成:聚乙烯醇(PVA)、聚環氧乙烷(PEO)、聚丙烯酸、聚乳酸(PLA)、聚乙醇酸(PGA)、PLA / PGA共聚物和聚己內酯(PCL)。In a preferred embodiment, the superabsorbent material is a sponge. In another specific embodiment, the superabsorbent material is attached to the surface of the electrodes 103, and the superabsorbent material is made of a material selected from the group consisting of: polyvinyl alcohol (PVA), polyethylene oxide (PEO), polyacrylic acid, polylactic acid (PLA), polyglycolic acid (PGA), PLA/PGA copolymer and polycaprolactone (PCL).
於一較佳實施例,該些電極103之數量不小於3。更特定而言,該些電極103之二係用作為陽極與陰極。為了有較佳的電化學效能,陽極與陰極係布置成一交錯排列的梳狀電極結構,而另一電極為參考電極,以避免電壓衰退,例如因為在稀酸液、鹽水等離子電解質中的電流流過所產生的歐姆電壓。電壓衰退可能影響藥劑遞送之準確度,故須避免以獲得精確的電位測量。若設有第四電極或更多電極,該等剩餘之電極則為冗餘電極。該些冗餘電極可以避免一電極發生突然失效時的修復的不便。In a preferred embodiment, the number of the electrodes 103 is not less than 3. More specifically, two of the electrodes 103 are used as anodes and cathodes. For better electrochemical performance, the anodes and cathodes are arranged in a staggered comb electrode structure, and the other electrode is a reference electrode to avoid voltage decay, such as the ohmic voltage generated by the flow of current in dilute acid, saline plasma electrolyte. Voltage decay may affect the accuracy of drug delivery, so it must be avoided to obtain accurate potential measurement. If a fourth electrode or more electrodes are provided, the remaining electrodes are redundant electrodes. The redundant electrodes can avoid the inconvenience of repairing an electrode when it fails suddenly.
為了改善電化學效率,任一電極103皆可透過複數個通孔1013電性連接電子裝置104。於一較佳實施例,陽極與陰極上各具有20個通孔。圖3及圖4顯示其與其他設計之電極電化學效率的比較,其中陽極與陰極各具有20個通孔的設計(電極與接觸墊位在對面側,具有40通孔)相較於不具有通孔設計之電極(電極與接觸墊位在同側),流速與總遞送體積增加約30%;相較於陰極與陽極各僅有一通孔之設計(電極與接觸墊位在對面側,具有2通孔),流速與總遞送體積亦增加約20%。To improve electrochemical efficiency, any electrode 103 can be electrically connected to the electronic device 104 through a plurality of through holes 1013. In a preferred embodiment, the anode and the cathode each have 20 through holes. Figures 3 and 4 show the comparison of the electrochemical efficiency of the electrode with other designs, where the design with 20 through holes in the anode and cathode (the electrode and the contact pad are on opposite sides, with 40 through holes) increases the flow rate and the total delivery volume by about 30% compared to the electrode without through holes (the electrode and the contact pad are on the same side); compared to the design with only one through hole in the cathode and anode (the electrode and the contact pad are on opposite sides, with 2 through holes), the flow rate and the total delivery volume also increase by about 20%.
該第一表面1011和該些電極103可塗佈一親水層,用以改良電化學效率,其塗佈材料包括但不限於:像是聚乙烯苯酚(PVP)、聚丙烯酸(PAA)、聚環氧乙烷(PEO)、多醣類、質子交換膜(proton exchange membrane)(如磺化聚四氟乙烯(sulfonated tetrafluoroethylene,又稱Nafion))、奈米結構金屬、環氧樹脂,以及由前述材料所製造之高分子纖維製品。The first surface 1011 and the electrodes 103 may be coated with a hydrophilic layer to improve electrochemical efficiency. The coating materials include but are not limited to: polyvinyl phenol (PVP), polyacrylic acid (PAA), polyethylene oxide (PEO), polysaccharides, proton exchange membranes (such as sulfonated tetrafluoroethylene (Nafion)), nanostructured metals, epoxy resins, and polymer fiber products made from the aforementioned materials.
該塗佈的一親水層係用於確保該電化學幫浦10之第一表面1011具有親水性,於電化學反應時可連續地產生氣體。與傳統未處理的電極相比之下,該經塗佈電極可以提供較佳的氣體可溶性。The coated hydrophilic layer is used to ensure that the first surface 1011 of the electrochemical pump 10 has hydrophilicity, and can continuously generate gas during the electrochemical reaction. Compared with the conventional untreated electrode, the coated electrode can provide better gas solubility.
為了進一步強化該電化學效率,有效的是改變電極的幾何。在某些具體實施例中,倒梯形的電極係透過與改良氧電漿處理的改良標準電子射束微影術或改良光微影術程序、改良反應離子蝕刻(RIE)、改良深反應離子蝕刻(DRIE)或改良感應耦合電漿(ICP)的方式製成。另一方面,該電化學效率可藉由改變該電極的形狀而加強。於一具體實施例,該電極103係製成為倒梯形的形狀,以產生強烈電場並引起更大量的氣體產生。於另一具體實施例,該電化學幫浦10之親水性可利用親水處理達成,像是氧電漿處理、化學蝕刻與力學摩擦。In order to further enhance the electrochemical efficiency, it is effective to change the geometry of the electrode. In some specific embodiments, the inverted trapezoidal electrode is made by a modified standard electron beam lithography or modified photolithography process with modified oxygen plasma treatment, modified reactive ion etching (RIE), modified deep reactive ion etching (DRIE) or modified inductively coupled plasma (ICP). On the other hand, the electrochemical efficiency can be enhanced by changing the shape of the electrode. In one specific embodiment, the electrode 103 is made into an inverted trapezoidal shape to generate a strong electric field and cause a larger amount of gas to be generated. In another specific embodiment, the hydrophilicity of the electrochemical pump 10 can be achieved by hydrophilic treatment, such as oxygen plasma treatment, chemical etching and mechanical friction.
該電子裝置104電性連接該些接點1015,用於向該些電極103提供電力並控制其產生電化學反應之時間及功率。於一較佳實施例,該電子裝置104係組態為可拆卸式,可與該電化學幫浦10之其餘組件組裝及分離。The electronic device 104 is electrically connected to the contacts 1015 to provide power to the electrodes 103 and control the time and power of the electrochemical reaction. In a preferred embodiment, the electronic device 104 is configured to be detachable and can be assembled and separated from the other components of the electrochemical pump 10.
於一具體實施例,該電子裝置104包括:一電路板1041;一輸入端口1042;和一輸出端口1043。In a specific embodiment, the electronic device 104 includes: a circuit board 1041; an input port 1042; and an output port 1043.
該輸出端口1043係將該電路板1041電性連接至該接點1015,以控制該些電極103,進而控制該電化學幫浦10產生氣體。該輸入端口1042其中一端電性連接至該電路板1041,另一端為電源之輸入口,可電性連接至一電源,以提供該電化學幫浦10電力。該電源可為一外接電源,或包含於該電子裝置104中。The output port 1043 electrically connects the circuit board 1041 to the contact 1015 to control the electrodes 103 and further control the electrochemical pump 10 to generate gas. One end of the input port 1042 is electrically connected to the circuit board 1041, and the other end is the input port of the power source, which can be electrically connected to a power source to provide power to the electrochemical pump 10. The power source can be an external power source or included in the electronic device 104.
於一實施例,該電子裝置104更包括一電源1044,該電源1044係電性連結至該輸入端口1042。In one embodiment, the electronic device 104 further includes a power source 1044 , which is electrically connected to the input port 1042 .
於一較佳實施例,該電子裝置104更包含一驅動電路構件,以控制該電子裝置104的開關。In a preferred embodiment, the electronic device 104 further includes a driving circuit component to control the switch of the electronic device 104.
據此,該輸出端口1043做為該等電子裝置104與該電化學幫浦10其餘組件之間的電橋。該輸出端口1043可為一種微型連接器,如彈簧針(Pogo pin)。 Accordingly, the output port 1043 serves as a bridge between the electronic devices 104 and the remaining components of the electrochemical pump 10. The output port 1043 may be a micro connector, such as a pogo pin.
如圖2所示,本揭露係提供一種藥劑遞送裝置200,包括:一容器,為一注射筒20;和該電化學幫浦10。 As shown in FIG. 2 , the present disclosure provides a drug delivery device 200, comprising: a container, which is a syringe 20; and the electrochemical pump 10.
該注射筒20具有一第一開口21,一第二開口22,和一間隔件23。該第一開口21和該第二開口22彼此相對。 The syringe 20 has a first opening 21, a second opening 22, and a spacer 23. The first opening 21 and the second opening 22 are opposite to each other.
於一較佳實施例,該注射筒20進一步具有一注射針頭24,其設置於該第一開口21。 In a preferred embodiment, the syringe 20 further has an injection needle 24, which is disposed at the first opening 21.
於一實施例,該藥劑遞送裝置200夠微小以能遞送微量之藥劑,其中該注射筒20之體積較佳地係為微升(microliter)量級(0.1-500microliter)。 In one embodiment, the drug delivery device 200 is small enough to deliver trace amounts of drugs, wherein the volume of the syringe 20 is preferably in the microliter range (0.1-500 microliter).
於另一實施例,該藥劑遞送裝置200能遞送高濃稠度、大體積之藥劑,其中該注射筒20之體積較佳地係為毫升(mL)量級(0.1-500mL)。 In another embodiment, the drug delivery device 200 can deliver high-concentration, large-volume drugs, wherein the volume of the syringe 20 is preferably in the milliliter (mL) range (0.1-500mL).
根據本揭露之實施例,該間隔件23設置於該注射筒20內,並將該注射筒20分隔為一第一腔室201和一第二腔室202,該第一腔室201係用於容置該藥劑,以及該第二腔室202係用於容納該電化學幫浦之容置電解液之空間102及其內之電解液1021。 According to the embodiment disclosed herein, the partition 23 is disposed in the syringe 20 and divides the syringe 20 into a first chamber 201 and a second chamber 202. The first chamber 201 is used to contain the drug, and the second chamber 202 is used to contain the electrolyte space 102 of the electrochemical pump and the electrolyte 1021 therein.
根據本揭露之實施例,該容器可為一注射筒20,由透明或半透明材料製成,以及該容器,例如一注射筒,可為剛性或具有可撓性。較佳地,該注射筒20係剛性材料所組成,其材料包括但不限於:玻璃(例如石英、熔融二氧化矽、鹼石灰、矽酸鹽及硼矽酸鹽)、聚合物/塑膠(例如聚碳酸酯(PC)、聚甲基丙烯酸甲酯(PMMA)、聚丙烯(PP)、聚乙烯(PE)、乙烯對苯二甲酸酯(PET)、聚乳酸(PLA)、熱塑性彈性體(TPE)及聚對二甲苯、COP或COC之環烯烴聚合物)、橡膠(天然橡膠與橡膠)、膠體(環氧樹脂、矽膠和丙烯酸樹脂)與傳導聚合物(聚芴、聚聯苯化合物、聚芘、聚薁、聚萘、聚吡咯(PPY)、聚苯胺(PANI)、聚噻吩(PT)、聚(3、4-乙撑二氧噻吩)(PEDOT)、聚對苯硫(PPS)、聚乙炔(PAC)及聚苯並乙烯(PPV))。According to an embodiment of the present disclosure, the container may be a syringe 20, made of a transparent or translucent material, and the container, such as a syringe, may be rigid or flexible. Preferably, the syringe 20 is made of a rigid material, including but not limited to: glass (such as quartz, fused silica, alkali lime, silicate and borosilicate), polymer/plastic (such as polycarbonate (PC), polymethyl methacrylate (PMMA), polypropylene (PP), polyethylene (PE), ethylene terephthalate (PET), polylactic acid (PLA), thermoplastic elastomer (TPE) and polyparaxylene, C Cyclic olefin polymers of OP or COC), rubbers (natural rubber and rubber), colloids (epoxy resins, silicones and acrylic resins) and conductive polymers (polyfluorene, polybiphenyl compounds, polypyrene, polyazulene, polynaphthalene, polypyrrole (PPY), polyaniline (PANI), polythiophene (PT), poly(3,4-ethylenedioxythiophene) (PEDOT), polyp-phenylene sulfide (PPS), polyacetylene (PAC) and polystyrene (PPV)).
於本實施例,該間隔件23係一隔膜(diaphragm)。該隔膜可由熱塑性彈性體(TPE)、苯乙烯-乙烯-丁烯-苯乙烯嵌段共聚物(SEBS)、苯乙烯-乙烯-丙烯-苯乙烯型嵌段共聚物(SEPS)、及聚對二甲苯等材料構成,但本揭露不限於此。但於另一實施例,該間隔件23亦可為一阻檔件,以一橡膠塞所構成,該膠塞可由橡膠、聚四氟乙烯(Teflon)、矽膠(silicone)、熱塑性彈性體(TPE)、苯乙烯-乙烯-丁烯-苯乙烯嵌段共聚物(SEBS)、苯乙烯-乙烯-丙烯-苯乙烯型嵌段共聚物(SEPS)、及聚對二甲苯等材料構成。In this embodiment, the spacer 23 is a diaphragm. The diaphragm can be made of materials such as thermoplastic elastomer (TPE), styrene-ethylene-butylene-styrene block copolymer (SEBS), styrene-ethylene-propylene-styrene block copolymer (SEPS), and polyparaxylene, but the present disclosure is not limited thereto. However, in another embodiment, the spacer 23 can also be a blocking member, which is made of a rubber plug. The rubber plug can be made of materials such as rubber, polytetrafluoroethylene (Teflon), silicone, thermoplastic elastomer (TPE), styrene-ethylene-butylene-styrene block copolymer (SEBS), styrene-ethylene-propylene-styrene block copolymer (SEPS), and polyparaxylene.
於本揭露,該電化學幫浦10設置於該注射筒之第二開口22,並使該電化學幫浦10與該注射筒20緊密結合密封該第二開口22,避免容納於其內之電解液1021以及該電化學幫浦10工作所產生之氣體外漏。是以,該電解液1021若受電化學反應,而產生氣體,將導致該第二腔室202之壓力高於該第一腔室201之壓力,並使該間隔件23朝該第一開口21推進,進而輸出藥劑。故該間隔件23之設置須使該第一腔室201和該第二腔室202彼此隔離,以免電解液和藥劑混合。該密封方法包括使用墊片(如O形環)、使用黏著劑密封,或利用焊接(如超音波、熱或雷射焊接)密封,但應不限於此。In the present disclosure, the electrochemical pump 10 is disposed at the second opening 22 of the syringe, and the electrochemical pump 10 is tightly combined with the syringe 20 to seal the second opening 22, so as to prevent the electrolyte 1021 contained therein and the gas generated by the operation of the electrochemical pump 10 from leaking out. Therefore, if the electrolyte 1021 is subjected to an electrochemical reaction and generates gas, the pressure of the second chamber 202 will be higher than the pressure of the first chamber 201, and the partition 23 will be pushed toward the first opening 21, thereby outputting the agent. Therefore, the partition 23 must be disposed to isolate the first chamber 201 and the second chamber 202 from each other to prevent the electrolyte and the agent from mixing. The sealing method includes, but is not limited to, using a gasket (such as an O-ring), sealing using an adhesive, or sealing using welding (such as ultrasonic, heat, or laser welding).
於一實施例,該第二開口22密封後,該電化學幫浦10為可拆卸式。In one embodiment, after the second opening 22 is sealed, the electrochemical pump 10 is detachable.
於另一實施例,該第二開口22密封後,該電化學幫浦10為不可拆卸式。In another embodiment, after the second opening 22 is sealed, the electrochemical pump 10 is non-detachable.
於本說明書實施例揭示之內容,本發明所屬領域具有通常知識者可明顯得知前述實施例僅為例示而非限制;具本發明所屬技術領域通常知識者可藉由諸多變換、替換而實施,並不與本發明之技術特徵有所差異。依據說明書實施例,本發明可有多種變換仍無礙於實施。本說明書提供之請求項界定本發明之範圍,該範圍涵蓋前述方法與結構及與其相等之發明。In the contents disclosed in the embodiments of this specification, it is obvious to those with ordinary knowledge in the field to which the present invention belongs that the aforementioned embodiments are only illustrative and not restrictive; those with ordinary knowledge in the technical field to which the present invention belongs can implement the present invention through many changes and substitutions, which do not differ from the technical features of the present invention. According to the embodiments of the specification, the present invention can be implemented in many ways without hindering its implementation. The claims provided in this specification define the scope of the present invention, which covers the aforementioned methods and structures and inventions equivalent thereto.
10:電化學幫浦 101:基板 1011:第一表面 1012:第二表面 1013:通孔 1014:導電材料 1015:接點 102:容置電解液之空間 1021:電解液 103:電極 104:電子裝置 1041:電路板 1042:輸入端口 1043:輸出端口 1044:電源 200:藥劑遞送裝置 20:注射筒 201:第一腔室 202:第二腔室 21:第一開口 22:第二開口 23:間隔件 24:注射針頭 10: electrochemical pump 101: substrate 1011: first surface 1012: second surface 1013: through hole 1014: conductive material 1015: contact 102: space for electrolyte 1021: electrolyte 103: electrode 104: electronic device 1041: circuit board 1042: input port 1043: output port 1044: power supply 200: drug delivery device 20: syringe 201: first chamber 202: second chamber 21: first opening 22: second opening 23: spacer 24: injection needle
圖1係本揭露之電化學幫浦結構示意圖。FIG. 1 is a schematic diagram of the electrochemical pump structure of the present disclosure.
圖2係本揭露之藥劑遞送裝置之剖面圖。FIG. 2 is a cross-sectional view of the drug delivery device disclosed herein.
圖3係電化學幫浦流速與通孔數量之關係圖。FIG. 3 is a graph showing the relationship between the electrochemical pump flow rate and the number of through holes.
圖4係電化學幫浦總遞送體積與通孔數量之關係圖。FIG. 4 is a graph showing the relationship between the total electrochemical pump delivery volume and the number of through holes.
無without
10:電化學幫浦 10:Electrochemical pump
101:基板 101: Substrate
1011:第一表面 1011: First surface
1012:第二表面 1012: Second surface
1013:通孔 1013:Through hole
1014:導電材料 1014: Conductive materials
1015:接點 1015: Contact
102:容置電解液之空間 102: Space for electrolyte
1021:電解液 1021:Electrolyte
103:電極 103:Electrode
104:電子裝置 104: Electronic devices
1041:電路板 1041: Circuit board
1042:輸入端口 1042: Input port
1043:輸出端口 1043: output port
1044:電源 1044: Power supply
Claims (21)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW110140846A TWI840716B (en) | 2021-11-02 | Electrochemical pump and its drug-delivery device |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW110140846A TWI840716B (en) | 2021-11-02 | Electrochemical pump and its drug-delivery device |
Publications (2)
Publication Number | Publication Date |
---|---|
TW202319080A TW202319080A (en) | 2023-05-16 |
TWI840716B true TWI840716B (en) | 2024-05-01 |
Family
ID=
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8386030B2 (en) | 2005-08-08 | 2013-02-26 | Tti Ellebeau, Inc. | Iontophoresis device |
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8386030B2 (en) | 2005-08-08 | 2013-02-26 | Tti Ellebeau, Inc. | Iontophoresis device |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11725640B2 (en) | Electroosmotic pump | |
Lee et al. | Stretchable ionics–a promising candidate for upcoming wearable devices | |
US9199201B2 (en) | Self contained electroosmotic pump and method of making thereof | |
CN217548795U (en) | Electrochemical pump for drug delivery and drug delivery device thereof | |
US20220226565A1 (en) | Pump for measuring pressure of fluid to be transferred, fluid transport system using the same, and method for operating the system | |
CN111043005B (en) | Micropump based on capillary phenomenon and electrowetting phenomenon | |
TWM627591U (en) | Electrochemical pump and its drug-delivery device | |
TWI840716B (en) | Electrochemical pump and its drug-delivery device | |
WO2023078293A1 (en) | Electrochemical pump for medicament delivery, and medicament delivery device thereof | |
CN103573576A (en) | Magnetohydrodynamic micropump | |
KR20160007718A (en) | Microfluidic fuel cell | |
TW202319080A (en) | Electrochemical pump and its drug-delivery device | |
AU2022381167A1 (en) | Electrochemical pump for medicament delivery, and medicament delivery device thereof | |
EP3498373A1 (en) | Microfluidic device and manufacturing method therefor | |
EP2791506A1 (en) | Improvements in and relating to electroosmotic pumps | |
CN111030418B (en) | Double-cavity micropump based on electrowetting phenomenon | |
Sheybani et al. | Rapid and repeated bolus drug delivery enabled by high efficiency electrochemical bellows actuators | |
US11213821B2 (en) | Microfluidic device and manufacturing method therefor | |
Ge et al. | Pump-valve dual-functional liquid metal soft actuators | |
JP2011144692A (en) | Fluid transport device using conductive high polymer | |
US20230077910A1 (en) | Electroosmotic pump | |
WO2020041373A1 (en) | Device for pumping liquid by electrolysis in a compact body | |
TW202220709A (en) | Electrochemical pump device of grid combined electrode | |
KR20230125535A (en) | Fluid transfer pump apparatus | |
KR20230125547A (en) | Electro-osmotic pump and power supply ofr electro-osmotic pump |